These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
161 related items for PubMed ID: 12144820
1. Loss of Fhit expression as a potential marker of malignant progression in preinvasive squamous cervical cancer. Butler D, Collins C, Mabruk M, Leader MB, Kay EW. Gynecol Oncol; 2002 Aug; 86(2):144-9. PubMed ID: 12144820 [Abstract] [Full Text] [Related]
3. Loss of fhit expression in invasive cervical carcinomas and intraepithelial lesions associated with invasive disease. Connolly DC, Greenspan DL, Wu R, Ren X, Dunn RL, Shah KV, Jones RW, Bosch FX, Muñoz N, Cho KR. Clin Cancer Res; 2000 Sep; 6(9):3505-10. PubMed ID: 10999736 [Abstract] [Full Text] [Related]
4. p16INK4A, CDC6, and MCM5: predictive biomarkers in cervical preinvasive neoplasia and cervical cancer. Murphy N, Ring M, Heffron CC, King B, Killalea AG, Hughes C, Martin CM, McGuinness E, Sheils O, O'Leary JJ. J Clin Pathol; 2005 May; 58(5):525-34. PubMed ID: 15858126 [Abstract] [Full Text] [Related]
5. FHIT alterations in cancerous and non-cancerous cervical epithelium. Yoshino K, Enomoto T, Nakamura T, Sun H, Ozaki K, Nakashima R, Wada H, Saitoh J, Watanabe Y, Noda K, Murata Y. Int J Cancer; 2000 Jan 01; 85(1):6-13. PubMed ID: 10585575 [Abstract] [Full Text] [Related]
6. Decreased expression of human papillomavirus E2 protein and transforming growth factor-beta1 in human cervical neoplasia as an early marker in carcinogenesis. Torng PL, Chan WY, Lin CT, Huang SC. J Surg Oncol; 2003 Sep 01; 84(1):17-23. PubMed ID: 12949986 [Abstract] [Full Text] [Related]
8. P16 immunostaining and HPV testing in histological specimens from the uterine cervix. Capobianco G, Marras V, Wenger JM, Santeufemia DA, Ambrosini G, Lutzoni R, Dessole M, Cherchi PL. Eur J Gynaecol Oncol; 2013 Sep 01; 34(3):227-30. PubMed ID: 23967551 [Abstract] [Full Text] [Related]
9. FHIT and C-MYC expression in cervical histology and cytology as biomarkers for detecting high-grade intraepithelial neoplasia in human papillomavirus-positive women. Yang F, Cui Z, Liao Y, Tian R, Fan W, Jin Z, Hu Z, Yao S. Cancer Biomark; 2020 Sep 01; 27(3):303-312. PubMed ID: 31771040 [Abstract] [Full Text] [Related]
10. [Interaction between fragile histidine triad methylation, protein expression and human papillomavirus 16 infection in cervical carcinogenesis]. Liu XZ, Nan J, Li J, Li Y, Ding L, Wang JT. Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Jun 01; 37(6):858-62. PubMed ID: 27346116 [Abstract] [Full Text] [Related]
11. HR-HPV E6/E7 mRNA In Situ Hybridization: Validation Against PCR, DNA In Situ Hybridization, and p16 Immunohistochemistry in 102 Samples of Cervical, Vulvar, Anal, and Head and Neck Neoplasia. Mills AM, Dirks DC, Poulter MD, Mills SE, Stoler MH. Am J Surg Pathol; 2017 May 01; 41(5):607-615. PubMed ID: 28403015 [Abstract] [Full Text] [Related]
13. Assessment of the frequency of genetic alterations (LOH/MSI) in patients with intraepithelial cervical lesions with HPV infection: a pilot study. Migdalska-Sęk M, Karowicz-Bilińska A, Pastuszak-Lewandoska D, Czarnecka KH, Nawrot E, Domańska-Senderowska D, Kiszałkiewicz J, Brzeziańska-Lasota E. Med Oncol; 2016 May 22; 33(5):51. PubMed ID: 27090798 [Abstract] [Full Text] [Related]
14. p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears. Murphy N, Ring M, Killalea AG, Uhlmann V, O'Donovan M, Mulcahy F, Turner M, McGuinness E, Griffin M, Martin C, Sheils O, O'Leary JJ. J Clin Pathol; 2003 Jan 22; 56(1):56-63. PubMed ID: 12499437 [Abstract] [Full Text] [Related]
15. Investigating Diagnostic Problems of CIN1 and CIN2 Associated With High-risk HPV by Combining the Novel Molecular Biomarker PanHPVE4 With P16INK4a. van Baars R, Griffin H, Wu Z, Soneji YJ, van de Sandt M, Arora R, van der Marel J, Ter Harmsel B, Jach R, Okon K, Huras H, Jenkins D, Quint W, Doorbar J. Am J Surg Pathol; 2015 Nov 22; 39(11):1518-1528. PubMed ID: 26379150 [Abstract] [Full Text] [Related]
16. Assessment of correlation between p16INK4a staining, specific subtype of human papillomavirus, and progression of LSIL/CIN1 lesions: first comparative study. Razmpoosh M, Sansregret A, Oligny LL, Patey N, Dormoy-Raclet V, Ducruet T, Bouron-Dal Soglio D. Am J Clin Pathol; 2014 Jul 22; 142(1):104-10. PubMed ID: 24926093 [Abstract] [Full Text] [Related]
17. Folate deficiency and FHIT hypermethylation and HPV 16 infection promote cervical cancerization. Bai LX, Wang JT, Ding L, Jiang SW, Kang HJ, Gao CF, Chen X, Chen C, Zhou Q. Asian Pac J Cancer Prev; 2014 Jul 22; 15(21):9313-7. PubMed ID: 25422218 [Abstract] [Full Text] [Related]
18. Carcinosarcoma of the uterine cervix: a report of eight cases with immunohistochemical analysis and evaluation of human papillomavirus status. Grayson W, Taylor LF, Cooper K. Am J Surg Pathol; 2001 Mar 22; 25(3):338-47. PubMed ID: 11224604 [Abstract] [Full Text] [Related]